Chemours (CC) PT Lowered to $14 at RBC Capital

May 8, 2025 10:09 AM

RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $14.00 (from $17.00) while maintaining a Outperform rating.

No results found